ARCHIVES

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Ethics Commission to Meet In L.A.

September 4, 1981

Obese Men More Likely To Have Aggressive Tumors

February 27, 2004

Wichita CCOP Stopped Accrual For Two Months, PI Says.

May 12, 2006

NCAB Subcommittee drafting Report Bioassay-Human Risk Relationship

February 16, 1979

USDA Expands Role In 5 A Day Partnership

April 26, 2002

Ohio State recruits neurosurgeon from Harvard to lead new department.

January 9, 2004